Trial Profile
Oral lornoxicam for acute migraine without aura, a randomised controlled study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Feb 2015
Price :
$35
*
At a glance
- Drugs Lornoxicam (Primary)
- Indications Migraine without aura
- Focus Therapeutic Use
- 16 Feb 2015 New trial record